BIODESIX, INC. Operating Lease, Expense
BIODESIX, INC. (BDSX) reported Operating Lease, Expense of $600.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-05
- BIODESIX, INC. operating lease, expense for the quarter ending 2026-06-30 was $600.00K, a 0.00% change year-over-year.
- BIODESIX, INC. operating lease, expense for the quarter ending 2026-03-31 was $600.00K, a 0.00% change year-over-year.
- BIODESIX, INC. operating lease, expense for the quarter ending 2025-12-31 was $600.00K, a 0.00% change year-over-year.
- BIODESIX, INC. operating lease, expense for the quarter ending 2025-09-30 was $600.00K, a 0.00% change year-over-year.
- BIODESIX, INC. operating lease, expense for fiscal 2025 was $2.30M, a 0.00% change from fiscal 2024.
- BIODESIX, INC. operating lease, expense for fiscal 2024 was $2.30M, a 46.51% decline from fiscal 2023.
- BIODESIX, INC. operating lease, expense for fiscal 2023 was $4.30M, a 65.38% increase from fiscal 2022.
- BIODESIX, INC. operating lease, expense for fiscal 2022 was $2.60M, a 116.67% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $600.00K 10-Q · filed 2026-08-05 | $1.20M 10-Q · filed 2026-08-05 | $1.80M derived: sum of 3 quarters · filed 2026-08-05 | $2.40M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $600.00K 10-Q · filed 2026-05-04 | $1.20M derived: sum of 2 quarters · filed 2026-05-04 | $1.80M derived: sum of 3 quarters · filed 2026-05-04 | $2.40M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.20M derived: sum of 2 quarters · filed 2026-02-26 | $1.80M derived: sum of 3 quarters · filed 2026-08-05 | $2.30M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $600.00K 10-Q · filed 2025-11-03 | $1.20M derived: sum of 2 quarters · filed 2026-08-05 | $1.70M 10-Q · filed 2025-11-03 | $2.40M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $600.00K 10-Q · filed 2026-08-05 | $1.20M 10-Q · filed 2026-08-05 | $600.00K 10-Q · filed 2025-08-07 | $1.80M derived: sum of 3 quarters · filed 2026-08-05 | $2.40M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $600.00K 10-Q · filed 2026-05-04 | $1.20M derived: sum of 2 quarters · filed 2026-05-04 | $1.80M derived: sum of 3 quarters · filed 2026-05-04 | $3.00M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.20M derived: sum of 2 quarters · filed 2026-02-26 | $2.40M derived: sum of 3 quarters · filed 2026-02-26 | $2.30M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $600.00K 10-Q · filed 2025-11-03 | $1.80M derived: sum of 2 quarters · filed 2025-11-03 | $1.70M 10-Q · filed 2025-11-03 | $3.40M derived: sum of 4 quarters · filed 2025-11-03 | ||
| 2024-06-30 | $1.20M 10-Q · filed 2025-08-07 | $600.00K 10-Q · filed 2024-08-07 | $1.20M 10-Q · filed 2025-08-07 | $2.80M derived: sum of 3 quarters · filed 2025-08-07 | $3.90M derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $600.00K 10-Q · filed 2025-05-13 | $1.60M derived: sum of 2 quarters · filed 2025-05-13 | $2.70M derived: sum of 3 quarters · filed 2025-05-13 | $3.80M derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $2.10M derived: sum of 2 quarters · filed 2025-03-03 | $3.20M derived: sum of 3 quarters · filed 2025-03-03 | $4.30M 10-K · filed 2025-03-03 | ||
| 2023-09-30 | $1.10M 10-Q · filed 2024-11-01 | $2.20M derived: sum of 2 quarters · filed 2024-11-01 | $3.30M 10-Q · filed 2024-11-01 | $4.20M derived: sum of 4 quarters · filed 2024-11-01 | ||
| 2023-06-30 | $1.10M 10-Q · filed 2024-08-07 | $2.20M 10-Q · filed 2024-08-07 | $3.10M derived: sum of 3 quarters · filed 2024-08-07 | $4.00M derived: sum of 4 quarters · filed 2024-08-07 | ||
| 2023-03-31 | $1.10M 10-Q · filed 2024-05-08 | $2.00M derived: sum of 2 quarters · filed 2024-05-08 | $2.90M derived: sum of 3 quarters · filed 2024-05-08 | $3.40M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $1.80M derived: sum of 2 quarters · filed 2024-03-01 | $2.30M derived: sum of 3 quarters · filed 2024-03-01 | $2.60M 10-K · filed 2024-03-01 | ||
| 2022-09-30 | $900.00K 10-Q · filed 2023-11-07 | $1.40M derived: sum of 2 quarters · filed 2023-11-07 | $1.70M 10-Q · filed 2023-11-07 | $2.00M derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | $500.00K 10-Q · filed 2023-08-07 | $800.00K 10-Q · filed 2023-08-07 | $1.10M derived: sum of 3 quarters · filed 2023-08-07 | $1.40M derived: sum of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | $300.00K 10-Q · filed 2023-05-11 | $600.00K derived: sum of 2 quarters · filed 2023-05-11 | $900.00K derived: sum of 3 quarters · filed 2023-05-11 | $1.20M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $600.00K derived: sum of 2 quarters · filed 2023-03-06 | $900.00K derived: sum of 3 quarters · filed 2023-03-06 | $1.20M 10-K · filed 2023-03-06 | ||
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-03 | $600.00K derived: sum of 2 quarters · filed 2022-11-03 | $900.00K 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-04 | $600.00K 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |